India Block speaks to paediatrician and TV writer Dr Neal Baer about the controversial technology and how it could reshape ...

CRISPR Therapeutics ($CRSP) has endured a tough year since gaining several important regulatory approvals for its ...

Sickle cell disease occurs when a child inherits two sickle cell genes—one from each parent. Lillian knew she carried the ...

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...

The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

CRISPR gene editing is widely regarded as one of the most important leaps in biomedical and agricultural research, with ...

Editas Medicine faces a downgrade to Underperform from BofA, citing competition, limited catalysts, and a reduced price ...

Kanglin Biotech is a China based company, focusing on the research, development and commercialization of first-in-class and best-in-class gene therapy drugs, most of which are targeted at diseases ...

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

The groundbreaking gene-editing tool that launched a patent war, earned its developers a Nobel Prize and stands poised to ...

The Sickle Cell Awareness Foundation is hosting its first ever gala on Saturday, Dec. 7, at the Edward Davis Center in St. Albans, from 4 to 8 p.m., according to ...